Variational AI Releases Enki 4 for Drug Discovery
Variational AI releases Enki 4, a new foundation model for small-molecule drug discovery featuring an improved algorithm and scalable architecture. It increases pre-trained target coverage from 592 to 760 targets. Additional details about performance, benchmarks, training data, and deployment are not available in the truncated description.
Scoring Rationale
Domain-specific foundation model update expands pre-training coverage, making it relevant to drug-discovery ML practitioners; however, the truncated description lacks benchmarks, validation, and deployment details, limiting immediate technical assessment.
Practice interview problems based on real data
1,500+ SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problemsStep-by-step roadmaps from zero to job-ready — curated courses, salary data, and the exact learning order that gets you hired.
Sources
- Read Original?Variational AI Releases Enki 4: Major Update to Foundation Model for Small-Molecule Drug Discovery